marimastat has been researched along with Kidney Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Z; Jia, H; Jin, X | 1 |
1 other study(ies) available for marimastat and Kidney Neoplasms
| Article | Year |
|---|---|
Inhibition of ADAM-17 more effectively down-regulates the Notch pathway than that of γ-secretase in renal carcinoma.
Topics: ADAM Proteins; ADAM17 Protein; Amyloid Precursor Protein Secretases; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Homeodomain Proteins; Humans; Hydroxamic Acids; Kidney Neoplasms; Neoplasm Staging; Receptor, Notch1; Receptors, Notch; Signal Transduction; Transcription Factor HES-1 | 2013 |